IMNM - CIK 0001472012
Immunome Inc. (IMNM) reported revenue of $6.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $6.94M | -23.2% |
| FY 2024 | $9.04M | -35.5% |
| FY 2023 | $14.02M | - |
Immunome Inc. (IMNM) reported revenue of $6.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.